[ad_1]
According to the World Health Organization (WHO), the disease vaccine trial program was launched for the first time in Malawi and vaccines were launched in Ghana and Kenya in the weeks that followed.
"RTS, S" and known as the name of the vaccine applied to children up to the age of 2 years is a product of the study reported that the vaccine, clinical tests prevented an average of 4 out of 10 cases of malaria in the said vaccine.
"We have seen great progress in the area of mosquito nets and some other malaria control measures over the last 15 years, but that progress has stopped and has been reversed in some areas," he said. in a statement. We need it and this vaccine is a promising tool to reach our goal. "found in the evaluation.
Every year, children under the age of five are affected by the disease, which accounts for nearly 435,000 lives worldwide.
class = & # 39;>
One of the most deadly diseases, malaria, which causes the death of the child every 2 minutes, is the most prevalent disease in Africa. It manifests as flu-like symptoms such as malaria, fever, chills, sweating, headache, nausea, vomiting, muscle aches, fatigue, febrile illness that occurs after 7 days of incubation with parasitic mosquitoes.
Source link
